WFI
VRTX icon

West Family Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

West Family Investments’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$842K Buy
1,695
+421
+33% +$187K 0.24% 75
2026
Q1 		$569K Sell
1,274
-1,054
-45% -$491K 0.2% 95
2025
Q4 		$1.06M Buy
2,328
+5
+0.2% +$2.15K 0.25% 78
2025
Q3 		$910K Sell
2,323
-40
-2% -$16.7K 0.2% 102
2025
Q2 		$1.05M Buy
2,363
+1,015
+75% +$468K 0.27% 73
2025
Q1 		$654K Sell
1,348
-1,304
-49% -$608K 0.25% 83
2024
Q4 		$1.07M Sell
2,652
-12
-0.5% -$5.56K 0.37% 52
2024
Q3 		$1.24M Buy
2,664
+126
+5% +$60.5K 0.42% 50
2024
Q2 		$1.19M Hold
2,538
– – 0.36% 57
2024
Q1 		$1.06M Buy
2,538
+44
+2% +$18.6K 0.33% 63
2023
Q4 		$1.01M Hold
2,494
– – 0.34% 58
2023
Q3 		$867K Hold
2,494
– – 0.3% 66
2023
Q2 		$878K Buy
2,494
+30
+1% +$10.1K 0.34% 65
2023
Q1 		$776K Buy
2,464
+26
+1% +$7.8K 0.31% 68
2022
Q4 		$704K Sell
2,438
-281
-10% -$85.6K 0.24% 74
2022
Q3 		$787K Buy
2,719
+130
+5% +$37.4K 0.33% 67
2022
Q2 		$730K Sell
2,589
-30
-1% -$8.03K 0.29% 68
2022
Q1 		$683K Buy
2,619
+311
+13% +$73.8K 0.19% 79
2021
Q4 		$507K Buy
2,308
+990
+75% +$193K 0.14% 126
2021
Q3 		$239K Sell
1,318
-1,664
-56% -$325K 0.06% 266
2021
Q2 		$601K Buy
+2,982
New +$624K 0.16% 107

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

West Family Investments's VRTX Position: Q2 2026 in Review

West Family Investments increased its Vertex Pharmaceuticals (VRTX) stake by 33% in Q2 2026, buying an estimated $187K and bringing the position to 1,695 shares worth $842K. The position accounts for 0.24% of the portfolio, ranked #75.

West Family Investments first reported a position in VRTX in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.24M in Q3 2024. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • West Family Investments held 1,695 shares of Vertex Pharmaceuticals worth $842K as of Q2 2026.
  • West Family Investments bought 421 Vertex Pharmaceuticals shares in Q2 2026, an estimated $187K.
  • Vertex Pharmaceuticals made up 0.24% of West Family Investments's portfolio in Q2 2026, its #75 holding.
  • West Family Investments first reported a position in Vertex Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
  • West Family Investments's Vertex Pharmaceuticals position peaked at $1.24M in Q3 2024.
  • 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on West Family Investments's 13F filing for Q2 2026, filed 10 Aug 2026.